NEW YORK, July 3, 2026, 09:14 EDT
- U.S. markets closed for the Independence Day holiday. UiPath wrapped the holiday-shortened week at $11.71.
- The stock jumped 11.2% since the June 26 close, topping both broad software names and Nasdaq-tied funds.
- Short interest was at 126.25 million shares, or 32.23% of the float, ahead of the rally.
- Next up is ARR. UiPath’s Q2 guidance points to $28 million to $33 million in net ARR added. That’s less than the $49 million added in Q1.
U.S. markets were closed Friday for the Independence Day holiday, so the last trade for UiPath, Inc. NYSE:PATH came on Thursday. Shares ended that session at $11.71, rising 1.39% for the day and gaining 11.2% from last Friday’s $10.53 close, historical data shows. The New York Stock Exchange and Nasdaq both count July 3 as a holiday in 2026.
The week wasn’t just about an “AI stock bounce.” UiPath surged and squeezed shorts, with cash on hand and a buyback program big enough to move the needle on its market cap.
| Instrument | Google Finance ticker | Jun. 26 close | Jul. 2 close | Change |
|---|---|---|---|---|
| UiPath | NYSE:PATH | $10.53 | $11.71 | up 11.2% |
| iShares Expanded Tech-Software Sector ETF | NYSEARCA:IGV | $88.20 | $93.57 | up 6.1% |
| SPDR S&P 500 ETF Trust | NYSEARCA:SPY | $728.99 | $744.78 | up 2.2% |
| Invesco QQQ Trust | NASDAQ:QQQ | $706.52 | $712.60 | up 0.9% |
UiPath shares finished the holiday-shortened week ahead of the iShares Expanded Tech-Software Sector ETF (NYSEARCA:IGV), SPDR S&P 500 ETF Trust (NYSEARCA:SPY) and Invesco QQQ Trust NASDAQ:QQQ, according to historical closes.
UiPath had 126.25 million shares short as of June 15, according to MarketWatch. That’s 32.23% of float. The 65-day average volume sits at 38.23 million shares; on Thursday, volume hit 58.4 million shares, or 153% of that moving average. At Thursday’s close, the short position was valued near $1.48 billion.
| Positioning measure | Latest reading | Investor read |
|---|---|---|
| Shares shorted | 126.25 mln | Bears are set in |
| Short interest as % of float | 32.23% | Heavy for this sector |
| July 2 turnover | 58.4 mln | 153% vs 65-day norm |
| Days to cover at 65-day pace | 3.3 | Quick squeeze risk |
| Short value at $11.71 | ~$1.48 bln | Big swings possible on price moves |
This doesn’t prove there was forced short covering. It does explain how the stock can make a big move on volume even if there’s no operating update that day. If buyers keep at it when U.S. trading starts again Monday, shorts could get squeezed. If volume dries up, focus swings back to ARR and guidance.
UiPath has been buying back stock. In March, it finished a $1 billion repurchase and put in place a new $500 million authorization. In the first quarter ended April 30, it repurchased $243.8 million of Class A shares. Operating cash flow was $131.9 million. The company had $1.42 billion in cash, cash equivalents and marketable securities as of April 30, down from $1.69 billion at Jan. 31.
| Capital item | Amount | Share of current market cap |
|---|---|---|
| Cash and marketable securities as of Apr. 30 | $1.42 bln | 23.0% |
| Buyback plan from March | $500 mln | 8.1% |
| Class A shares repurchased in Q1 | $243.8 mln | 3.9% |
| Operating cash flow for Q1 | $131.9 mln | 2.1% |
That’s worth noting since buybacks can take in supply, but in Q1 they ran at almost 1.85 times operating cash flow. The company’s market cap sits close to $6.18 billion, so the leftover buyback authorization is still sizable for traders to track. The cash hit isn’t zero, though.
The operating bar looks less clear. UiPath posted Q1 revenue of $418 million, a 17% gain, and ARR hit $1.901 billion, up 12%. The Q2 outlook is for revenue between $395 million and $400 million, with ARR ranging from $1.929 billion to $1.934 billion. That suggests net ARR growth of $28 million to $33 million from April 30 to July 31, down from Q1 net new ARR of $49 million.
| Metric | Q1 FY2027 posted | Q2 FY2027 outlook / implied |
|---|---|---|
| Revenue | $418 mln | $395 mln-$400 mln |
| ARR | $1.901 bln | $1.929 bln-$1.934 bln |
| Net new ARR | $49 mln | $28 mln-$33 mln implied |
| Non-GAAP operating income | $92 mln | About $75 mln |
UiPath CEO Daniel Dines said the company’s agentic products are now shifting from pilot to production use. Operating and Finance Chief Ashim Gupta said Q1 numbers were “exceeding our guidance” and called out “first quarter GAAP profitability for the first time.” UiPath, Inc.
Analysts haven’t picked a clear direction. The Benzinga analyst page shows a $14.43 consensus price target from 22 analysts. The last three calls—UBS, BMO Capital, and DA Davidson—average $12.33, around 6% over the stock’s last price in the snapshot.
The July 2 insider filing didn’t report a discretionary sale. Instead, Chief Legal Officer Brad Brubaker had 22,019 shares withheld at $10.87 for taxes on vested equity, according to a Form 4. He also bought 1,367 shares at $9.14 in the June 10 employee stock plan.
Not much on the calendar this week for company events. UiPath isn’t showing anything coming up for investors, and FINRA will publish short interest data from June 30 on July 10, according to the 2026 schedule. That data won’t reflect the full run higher in the stock over July 1-2.
